Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Sir Run Run Shaw Hospital

InstitutionResearch output, impact & collaborations

Sir Run Run Shaw Hospital is a research organisation in Hangzhou, CN. OpenAlex records 18,316 works and 1,359,495 citations for it. 7,001 researchers list it as their most recent affiliation.

18,316
Works
1,359,495
Citations
7,001
Researchers
29.1
Avg h-index

How has Sir Run Run Shaw Hospital's publication output changed over time?

ScholarIQpublication output · 2013–2023

Output grew0% over the shown period — from 1 works in 2013 to 1 in 2023.

1
1
2
2
1
2
1
1
1
201320142015201720192020202120222023

Who are the most-cited researchers behind Sir Run Run Shaw Hospital?

ScholarIQtop researchers by citations
1
Tingting Jiang · Image and Video Quality Assessment
257 works4,643 citations
2
Jiancang Zhou · Antibiotic Resistance in Bacteria
94 works2,314 citations
3
Chang Liu · Liver Disease Diagnosis and Treatment
119 works1,675 citations
4
Engeng Chen · Colorectal Cancer Surgical Treatments
39 works676 citations
5
Qiqi He · Quality and Supply Management
37 works634 citations

What are the most-cited papers on Sir Run Run Shaw Hospital?

ScholarIQmost cited works
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
Jin Li, Shukui Qin, Rui‐Hua Xu, Thomas Yau, Brigette Ma, Hongming Pan, Jianming Xu, Yuxian Bai, Yihebali Chi, Liwei Wang, Kun‐Huei Yeh, Feng Bi, Ying Cheng, Anh T. Le, Jen-Kou Lin, Tianshu Liu, Dong Ma, Christian Kappeler, J. Kalmus, Tae Won Kim
The Lancet Oncology. 2015822 Citations
Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
Călin Cainap, Shukui Qin, Wen‐Tsung Huang, Ik Joo Chung, Hongming Pan, Ying Cheng, Masatoshi Kudo, Yoon‐Koo Kang, Pei‐Jer Chen, Han-Chong Toh, Vera Gorbunova, Ferry A.L.M. Eskens, Jiang Qian, Mark D. McKee, Justin L. Ricker, Dawn M. Carlson, Saied El-Nowiem
Journal of Clinical Oncology. 2014636 CitationsOPEN ACCESS
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Zixian Wang, Chengxu Cui, Jun Yao, Yanqiao Zhang, Mengxia Li, Ji‐Feng Feng, Shujun Yang, Yun Fan, Jianhua Shi, Xizhi Zhang, Lin Shen, Yongqian Shu, Cailian Wang, Tianyang Dai, Teng Mao, Long Chen, Zengqing Guo, Bo Liu, Hongming Pan, Shundong Cang, Yi Jiang, Junye Wang, Min Ye, Zhendong Chen, Da Jiang, Qin Lin, Wei Ren, Junsheng Wang, Lin Wu, Yong Xu, Zhanhui Miao, Meili Sun, Conghua Xie, Ying Liu, Qifeng Wang, Lina Zhao, Qi Li, Canhong Huang, Ke Jiang, Kunyu Yang, Daojun Li, Yunpeng Liu, Zhitu Zhu, Rixin Chen, Liqun Jia, Wei Li, Wangjun Liao, Hongxu Liu, Daiyuan Ma, Jie Ma, Yanru Qin, Zhihong Shi, Qichun Wei, Ke Xiao, Yan Zhang, Ying Zhang, Xin Chen, Guanghai Dai, Jianxing He, Junhe Li, Guanghui Li, Yong Liu, Zhihua Liu, Xianglin Yuan, Junping Zhang, Zhichao Fu, Yifu He, Fang Ju, Zheng Liu, Peng Tang, Tiejun Wang, Weibo Wang, Jing Zhang, Xianming Luo, Xiongwen Tang, Rena May, Hui Feng, Sheng Yao, Patricia Keegan, Rui‐Hua Xu, Feng Wang
S25671836. 2022577 CitationsOPEN ACCESS
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer
Caicun Zhou, Yi‐Long Wu, Gongyan Chen, Xiaoqing Liu, Yunzhong Zhu, Shun Lü, Jifeng Feng, Jianxing He, Baohui Han, Jie Wang, Guoliang Jiang, Chunhong Hu, Hao Zhang, Gang Cheng, Xiangqun Song, You Lü, Hongming Pan, Wenjuan Zheng, Anny-Yue Yin
Journal of Clinical Oncology. 2015391 CitationsOPEN ACCESS
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
Jianming Xu, Haiping Jiang, Yueyin Pan, Kangsheng Gu, Shundong Cang, Lei Han, Yongqian Shu, Jiayi Li, Junhui Zhao, Hongming Pan, Suxia Luo, Yanru Qin, Qunyi Guo, Yuxian Bai, Ling Yang, Jianwei Yang, Zhilong Yan, Lei Yang, Yong Tang, Yifu He, Liangming Zhang, Xinjun Liang, Zuoxing Niu, Jingdong Zhang, Yong Mao, Yingmei Guo, Bo Peng, Ziran Li, Ying Liu, Yan Wang, Hui Zhou, ORIENT-16 Investigators, Hongmei Sun, Qi Wang, Junhe Li, Da Jiang, Weijian Guo, Jieer Ying, Shubin Wang, Aimin Zang, Shirong Cai, Chunhong Hu, Tao Zhang, Min Tao, Jun Liang, Qinsheng Mao, Minghui Zhang, Rui Mao, Hui Yang, Hongyu Zhang, Lin Shen, Jin Lu, Wenxin Li, Yamin Chen, Lei Chen, Zhixiang Zhuang, Chunmei Bai, Heli Liu, Jingtang Chen, Wangjun Liao, Meng Qiu, Rongfeng Song, Man Li, S. B. Qian, Yunpeng Liu, Jiang Liu, Dong Wang, Xianli Yin, Zhiming Huang
JAMA. 2023382 CitationsOPEN ACCESS

How much of the research on Sir Run Run Shaw Hospital is open access?

ScholarIQopen access share
58%OPEN ACCESS
Gold
25%
Green
8%
Hybrid
8%
Bronze
17%
Closed
42%

Related on ScholarIQ

RNA modifications and cancer
Top Topic
Cancer-related molecular mechanisms research
Top Topic
Antibiotic Resistance in Bacteria
Top Topic
Hepatocellular Carcinoma Treatment and Prognosis
Top Topic
Cancer Immunotherapy and Biomarkers
Top Topic
Ferroptosis and cancer prognosis
Top Topic
470M+ articles · free account